Table 3 Correlation of IHC expression of mutation-specific antibodies and EGFR exon 19 deletion subtype analyzed by GeneScan, TaqMan and direct sequencing.
From: Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer
EGFR EXON 19 DELETION SUBTYPE | 0 | 1+ | 2+ | 3+ |
|---|---|---|---|---|
15 bp N = 17 | 0/17 (0%) | 0/17 (0%) | 2/17 (11%) | 15/17 (89%) |
9 bp N = 4 | 2/4 (50%) | 2/4(50%) | 0/4 (0%) | 0/4 (0%) |
12 bp N = 1 | 1/1 (100%) | 0/1 (0%) | 0/1 (0%) | 0/1 (0%) |
18 bp N = 5 | 4/5 (80%) | 1/5 (20%) | 0/5 (0%) | 0/5 (0%) |
21 bp N = 1 | 1/1 (100%) | 0/1 (0%) | 0/1 (0%) | 0/1 (0%) |
24 bp N = 1 | 1/1 (100%) | 0/1 (0%) | 0/1 (0%) | 0/1 (0%) |